CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

NCT03408873 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder
Medication Adherence
Medication Non Adherence

Interventions

DRUG: Abilify Maintena
BEHAVIORAL: Customized Adherence Enhancement (CAE)

Sponsor

Martha Sajatovic

Collaborators

[object Object]